Items

• A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study (2013-05)

  D. Yoo, P. Hrycaj, P. Miranda, E. Ramiterre, M. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, May, 2013

• Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study (2016)

  D. Yoo, N. Prodanović, J. Jaworski, P. Miranda, E. Ramiterre, A. Lanzon, A. Baranauskaite, P. Wiland, C. Abud-Mendoza, B. Oparanov, S. Smiyan, H. Kim, S. Lee, S. Kim, W. Park, Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2016